Risk factors
Nomad Power Solutions (NMAD) risk factors
Item 1A of every Nomad Power Solutions, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors67 risks11 new9 dropped7 reworded
Nomad expanded into radiotherapy with the acquisition of Liora Technologies Europe Ltd in November 2025. The company faces a full valuation allowance due to federal tax law changes under H.R.1. Management experienced extensive executive turnover, including CEO and director resignations.
Filed Mar 31, 2026 - FY2024 10-K risk factors65 risks
Nomad Power Solutions faces going concern doubts and has no revenue, relying on unproven early-stage cancer research like lead product LB-100.
Filed Mar 24, 2025